Article

Efficacy of Simple Short-Term in Vitro Assays for Predicting the Potential of Metal Oxide Nanoparticles to Cause Pulmonary Inflammation

University of Edinburgh, Edinburgh, UK.
Environmental Health Perspectives (Impact Factor: 7.98). 03/2009; 117(2):241-7. DOI: 10.1289/ehp.11811
Source: PubMed

ABSTRACT

There has been concern regarding risks from inhalation exposure to nanoparticles (NPs). The large number of particles requiring testing means that alternative approaches to animal testing are needed.
We set out to determine whether short-term in vitro assays that assess intrinsic oxidative stress potential and membrane-damaging potency of a panel of metal oxide NPs can be used to predict their inflammogenic potency.
For a panel of metal oxide NPs, we investigated intrinsic free radical generation, oxidative activity in an extracellular environment, cytotoxicity to lung epithelial cells, hemolysis, and inflammation potency in rat lungs. All exposures were carried out at equal surface area doses.
Only nickel oxide (NiO) and alumina 2 caused significant lung inflammation when instilled into rat lungs at equal surface area, suggesting that these two had extra surface reactivity. We observed significant free radical generation with 4 of 13 metal oxides, only one of which was inflammogenic. Only 3 of 13 were significantly hemolytic, two of which were inflammogenic.
Potency in generating free radicals in vitro did not predict inflammation, whereas alumina 2 had no free radical activity but was inflammogenic. The hemolysis assay was correct in predicting the proinflammatory potential of 12 of 13 of the particles examined. Using a battery of simple in vitro tests, it is possible to predict the inflammogenicity of metal oxide NPs, although some false-positive results are likely. More research using a larger panel is needed to confirm the efficacy and generality of this approach for metal oxide NPs.

Download full-text

Full-text

Available from: Ken Donaldson
    • "In the context of this paper, the term ''catalytic'' is used in the sense of a classical catalyzed reaction, while ''biological'' activity circumscribes effects in biological systems. As in previous studies, ROS production was chosen as a suitable marker for biological effects, because the oxidative potential of nanoparticles is considered a good first indicator of nanotoxicity (Ayres et al., 2008; Kovacic & Somanathan, 2010; Lu et al., 2009; Nel et al., 2006; Xia et al., 2008). ROS production was measured both in a cell-free environment and in THP-1 (human monocytic leukemia) cell lines, after transferring the particles into suspension. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Palladium and nickel nanoparticles with variable but narrowly defined primary particle sizes in the range of 4-27 nm were investigated toward their catalytic activity and their ability to produce reactive oxygen species (ROS). The agglomerate size in the gas phase was between 50 and 150 nm, after transfer into solution probably larger. The catalytic activity was measured on the basis of CO oxidation to CO2. The formation of ROS was determined after transferring the particles into phosphate buffered saline (PBS), via the 2',7'-dichlorofluorescein method in a cell-free environment and with THP-1 cells. Activities were normalized with regard to catalyst surface area to enable a meaningful comparison of size effects. The solubility was measured for both materials and found to be 2 µg/ml for Ni and below the detection limit of 0.8 µg/ml for Pd. In the concentration range of about 4-250 µg/ml both materials induced a significant production of ROS in both acellular and cellular environments, with palladium being more active than nickel by several orders of magnitude. On an equal surface area concentration basis, both acellular and cellular ROS production showed a pronounced dependence on the primary particle size, with a maximum in the vicinity of 12 nm. The surface-specific catalytic activity also had a maximum at that size range. The correlation of these size effects is both surprising and - in combination with the poor solubility of palladium and nickel in PBS solution - a strong argument in favor of a particulate, catalytic mechanism for ROS production.
    No preview · Article · Mar 2015 · Nanotoxicology
    • "However, there are few studies in relation to its effects on membranes and this needs to be explored. The hemolysis assay is recommended as a reliable test for material biocompatibility (Lu et al. 2009). In this study, we compared the effect on erythrocytes from human, rat, and rabbit of three sizes of commercial aluminum oxide nanoparticles and micro-sized aluminum oxide particles. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Al2O3 is the most abundantly produced nanomaterial and has been used in diverse fields, including the medical, military, and industrial sectors. As there are concerns about the health effects of nanoparticles, it is important to understand how they interact with cells, and specifically with red blood cells. The hemolysis induced by three commercial nano-sized aluminum oxide particles (nanopowder 13 nm, nanopowder <50 nm, and nanowire 2-6 x 200-400 nm) was compared to aluminum oxide and has been studied on erythrocytes from humans, rats, and rabbits, in order to elucidate the mechanism of action and the influence of size and shape on hemolytic behavior. The concentrations inducing 50 % hemolysis (HC50) were calculated for each compound studied. The most hemolytic aluminum oxide particles were of nanopowder 13, followed by nanowire and nanopowder 50. The addition of albumin to PBS induced a protective effect on hemolysis in all the nano-forms of Al2O3, but not on Al2O3. The drop in HC50 correlated to a decrease in nanomaterial size, which was induced by a reduction of aggregation. Aluminum oxide nanoparticles are less hemolytic than other oxide nanoparticles and behave differently depending on the size and shape of the nanoparticles. The hemolytic behavior of aluminum oxide nanoparticles differs from that of aluminum oxide.
    No preview · Article · Feb 2015 · Journal of Nanoparticle Research
  • Source
    • "Some studies have demonstrated that pathogenic mechanisms initiated by bulk metal oxide and its NPs are dominated by inflammation-driven effects, including, oxidative stress, apoptosis and DNA damage (Borm et al., 2006; Lu et al., 2009; Xiong et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this work is to explore the protective of B vitamins (B3, B6 and B12) against the hepatotoxic potency of either bulk zinc oxide (ZnO-bulk) or its nanoparticles (ZnO-NPs)-induced liver damage in rats. ZnO- bulk or its NPs were administered orally (500 mg/kg b.w.) for 10 successive days. The results revealed that oral co-administration of combination of B vitamins (250 mg B3, 60 mg B6 and 0.6 mg B12/Kg body weight) daily for 3 weeks to rats intoxicated by either ZnO- bulk or its NPs markedly ameliorated increases in serum of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehdrogenase (LDH). The B vitamins also down-regulated increases in serum glucose level as well as increases in immuno-inflammatory biomarkers, including tumor necrosis factor-α (TNF-α) and C-reactive protein compared with intoxicated, untreated rats. Beside, the used agent successfully modulated the alterations in serum vascular endothelial growth factor (VEGF), attenuated liver oxidative DNA damage compared with ZnO intoxicated groups. We showed that the used B complex mitigated increased malondialdehyde (MDA), decrease in glutathione peroxidase (GPx) and increase in the apoptosis marker caspase 3 of liver tissue in response to either ZnO-bulk or its NP toxicity. In conclusion, early treatment with vitamin B complex may protect liver tissue from deleterious damage induced by the toxic effects of ZnO-bulk or its NPs.
    Full-text · Article · Jan 2015 · Pakistan journal of pharmaceutical sciences
Show more